Download presentation
Presentation is loading. Please wait.
Published byKlara Fredriksson Modified over 6 years ago
1
Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis Matthias Guckenberger, MD, Michael Allgäuer, MD, Steffen Appold, MD, Karin Dieckmann, MD, Iris Ernst, MD, Ute Ganswindt, MD, Richard Holy, MD, Ursula Nestle, MD, Meinhard Nevinny-Stickel, MD, Sabine Semrau, MD, Florian Sterzing, MD, Andrea Wittig, MD, Nicolaus Andratschke, MD Journal of Thoracic Oncology Volume 8, Issue 8, Pages (August 2013) DOI: /JTO.0b013e318293dc45 Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions
2
FIGURE 1 Patterns of implementation and practice of SBRT in 13 centers in Germany and Austria. SBRT, stereotactic body radiotherapy. Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e318293dc45) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions
3
FIGURE 2 Time trend of irradiation dose in stereotactic body radiotherapy. BED, biological effective dose; PTV, planning target volume. Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e318293dc45) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions
4
FIGURE 3 Freedom from local progression for the total patient population. Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e318293dc45) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions
5
FIGURE 4 Overall survival for the total patient population.
Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e318293dc45) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.